5/15/13 - Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders

4/3/13 - Atlanta can become Silicon Valley of biotechnology (Transcript) (Advisory)

3/5/13 - Galectin Therapeutics Inc. Receives OK from FDA to Proceed with First Human Clinical Trial for Treatment of Fatty Liver Disease with Advanced Fibrosis

2/19/13 - Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with the University of Georgia

7/25/12 - Reuters Article: Galectin Shares Jump on Analyst Report

Read More...

Galectin Therapeutics Annual Stockholder Meeting Presentation

                    May 23, 2013

Galectin rings NASDAQ
closing bell